The FDA awarded Apollo Endosurgery’s OverStitch Sx system FDA 510(k) clearance.
The FDA granted Ferring Pharmaceuticals approval to market Clenpiq, an oral solution for colon preparation.
CSA Medical announced the enrollment of the first patient into a multicenter study evaluating its spray cryotherapy on esophageal cancer patients. The patient was treated at Chapel Hill-based University of North Carolina’s Center for Esophageal Diseases and Swallowing.
More articles on gastroenterology:
9 GI leaders to know for November
Stock market week-in-review for 5 large GI companies — Nov. 20-24
6 insights into Crohn’s on a global level — US has 993k cases
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
